CTRI/2023/01/048785Not yet recruiting未知
Clinical Study Of Allergic Rhinitis(Iltehab e anaf hassasi)and its management with Unani Medicine
PG Department of Moalijat General Medicine0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- 未知
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Patients with following sign and symptoms suggesting the diagnosis of Allergic Rhinitis
- •a. Nasal Discharge
- •b. Sneezing
- •c. Nasal Obstruction
- •d. Dull Headache
- •f. Nasal itching
Exclusion Criteria
- •Age <15and >65 years were excluded from the study
- •Pregnant women with Allergic Rhinitis
- •Known cases of coronary artery disease, ischemic heart disease and myocardial infarction
- •Patients with Pulmonary disease such as Allergic Bronchial Asthma and other allergic systemic disorders
- •Deviated Nasal Septum and Sinusitis
- •Patients with other ENT diseases were exclude
Investigators
Similar Trials
Not yet recruiting
Phase 4
A STUDY ON HOMOEOPATHIC MANAGEMENT OF ALLERGIC COLDCTRI/2022/04/041644Dr Anand A Kulkarni
Not yet recruiting
Phase 1
Clinical study on the treatment of allergic rhinitis with Chinese herbal medicine desensitization Zhixiao Decoction: a randomized controlled trialallergic rhinitisITMCTR2100004670Shanghai Dongfang Hospital
Completed
Not Applicable
A ramdomized, double-binded clinical trial comparison of two dimensions of traditional medical precision medicine for allergic rhinitis: Syndrome differentiation-based treatment or staging treatment?Allergic rhinitisITMCTR2100005332Shenzhen Traditional Chinese Medicine Hospital
Completed
Phase 3
Once-Daily Investigational Nasal Spray In Adults And Adolescents With Seasonal Allergic Rhinitis (SAR)Rhinitis, Allergic, SeasonalNCT00197262GlaxoSmithKline288
Completed
Phase 3
Study In Adolescent And Adult Subjects 12 Years Of Age And Older With Seasonal Allergic Rhinitis To Assess Onset of ActionRhinitis, Allergic, SeasonalNCT00118729GlaxoSmithKline380